Von Hippel Lindau Disease: Two Sisters and one Disease
Keywords:
Von Hippel Lindau disease, hemangioblastomas, pheochromocytomaAbstract
Introduction: Von Hippel-Lindau disease is an autosomal dominantly inherited condition, which predisposes individuals to multiple malignancies. Germline pathogenic variants of the VHL gene induce individuals to specific types of benign, malignant and cyst-like tumors in many organ systems. Evaluation and treatment of these patients require a multidisciplinary approach. Penetrance is incomplete, but high in mutation carriers, so that almost all have developed characteristic tumors before the age of 60 years. The average life expectancy was less than 50 years before the current follow-up protocols, which should be started in childhood. Prognosis depends on early detection and treatment of these tumors.
Objective: To describe the evolution of the disease and the follow-up performed so far in the two sisters with similar diagnoses, but with different forms of evolution of the disease, despite being a genetic disease.
Case presentation: The case of two sisters with the same genetic disease is presented, with different cysts and tumors, as well as complications typical of their evolution, and classic images of these and their behavior are shown.
Conclusions: According to the proposed classifications for the disease, 80% are Type 1, with absence of pheochromocytoma, as in the cases of this research. The infrequent nature of the disease, the genetic characteristics and the variability of lesions in the same patient, benign and malignant, have an independent expression in each subject, as well as the response to established treatments.
Downloads
References
Lonser R, Glenn G, Walther M, Chew E, Libutti S, Linehan W, et al. Von Hippel-Lindau disease. Lancet. 2003;361(9374):2059-67. DOI: https://doi.org/10.1016/S0140-6736(03)13643-4
Wolters W, Dreijerink K, Giles R, van der Horst-Schrivers A, van Nesselrooij B, Zandee W, et al. Multidisciplinary integrated care pathway for Von Hippel-Lindau disease. Cancer. 2022;128(15):2871-9. DOI: https://doi.org/10.1002/cncr.34265
Villar K. Descripción de la enfermedad de Von Hippel-Lindau en tres familias españolas. An Med Interna (Madrid). 2002 [acceso 10/11/2024];19:352-6. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-71992002000700005&lng=es
Schunemann V, Huntoon K, Lonser R. Personalized Medicine for Nervous System Manifestations of Von Hippel-Lindau Disease. Front Surg. 2016;3:39. DOI: https://doi.org/10.3389/fsurg.2016.00039
Huntoon K, Wu T, Elder J, Butman J, Chew E, Linehan W, et al. Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in Von Hippel-Lindau disease. J Neurosurg. 2016;124(4):971-6. DOI: https://doi.org/10.3171/2015.4.JNS1533
Kanno H, Kuratsu J, Nishikawa R, Mishima K, Natsume A, Wakabayashi T, et al. Clinical features of patients bearing central nervous system hemangioblastoma in Von Hippel-Lindau disease. Acta Neurochir (Wien). 2013;155(1):1-7. DOI: https://doi.org/10.1007/s00701-012-1514-y
Lonser R, Butman J, Huntoon K, Asthagiri A, Wu T, Bakhtian K, et al. Prospective natural history study of central nervous system hemangioblastomas in Von Hippel-Lindau disease. J Neurosurg. 2014;120(5):1055-62. DOI: https://doi.org/10.3171/2014.1. JNS131431
Klingler J, Gläsker S, Bausch B, Urbach H, Krauss T, Jilg C, et al. Hemangioblastoma and Von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment. Childs Nerv Syst. 2020;36(10):2537-52. DOI: https://doig.org/10.1007/s00381-020-04712-5
Shepherd S, Drake W, Turajlic S. The road to systemic therapy in Von Hippel-Lindau (VHL) disease: ¿Are we there yet? Eur J Cancer. 2023;182:15-2. DOI: https://doi.org/10.1016/j.ejca.2022.12.011
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).